DK0859634T3 - Farmaceutiske præparater indeholdende blodpladeaggregeringsinhibitorer - Google Patents

Farmaceutiske præparater indeholdende blodpladeaggregeringsinhibitorer

Info

Publication number
DK0859634T3
DK0859634T3 DK96940256T DK96940256T DK0859634T3 DK 0859634 T3 DK0859634 T3 DK 0859634T3 DK 96940256 T DK96940256 T DK 96940256T DK 96940256 T DK96940256 T DK 96940256T DK 0859634 T3 DK0859634 T3 DK 0859634T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparations
platelet aggregation
preparations containing
aggregation inhibitors
containing platelet
Prior art date
Application number
DK96940256T
Other languages
Danish (da)
English (en)
Inventor
Karl M Gelotte
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603721.3A external-priority patent/GB9603721D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK0859634T3 publication Critical patent/DK0859634T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK96940256T 1995-10-27 1996-10-23 Farmaceutiske præparater indeholdende blodpladeaggregeringsinhibitorer DK0859634T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US590795P 1995-10-27 1995-10-27
GBGB9603721.3A GB9603721D0 (en) 1996-02-22 1996-02-22 Composition for inhibiting platelet aggregation
PCT/US1996/017193 WO1997015328A1 (en) 1995-10-27 1996-10-23 Pharmaceutical compositions containing platelet aggregation inhibitors

Publications (1)

Publication Number Publication Date
DK0859634T3 true DK0859634T3 (da) 2002-03-25

Family

ID=26308777

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96940256T DK0859634T3 (da) 1995-10-27 1996-10-23 Farmaceutiske præparater indeholdende blodpladeaggregeringsinhibitorer

Country Status (35)

Country Link
EP (1) EP0859634B1 (xx)
JP (1) JP3452367B2 (xx)
KR (1) KR100362799B1 (xx)
CN (1) CN1158107C (xx)
AT (1) ATE213648T1 (xx)
AU (1) AU712755B2 (xx)
BG (1) BG63623B1 (xx)
BR (1) BR9610878A (xx)
CA (1) CA2234364C (xx)
CO (1) CO4770960A1 (xx)
CY (1) CY2292B1 (xx)
CZ (1) CZ290381B6 (xx)
DE (1) DE69619540T2 (xx)
DK (1) DK0859634T3 (xx)
DZ (1) DZ2110A1 (xx)
EA (1) EA000628B1 (xx)
EE (1) EE03518B1 (xx)
ES (1) ES2171749T3 (xx)
HK (1) HK1017846A1 (xx)
HU (1) HU228757B1 (xx)
IL (1) IL123790A (xx)
IS (1) IS1948B (xx)
MX (1) MX9803275A (xx)
MY (1) MY116837A (xx)
NO (1) NO324415B1 (xx)
NZ (1) NZ323134A (xx)
PL (1) PL185744B1 (xx)
PT (1) PT859634E (xx)
SA (1) SA96170527B1 (xx)
SI (1) SI0859634T1 (xx)
SK (1) SK282353B6 (xx)
TR (1) TR199800716T2 (xx)
TW (1) TW385248B (xx)
UA (1) UA45423C2 (xx)
WO (1) WO1997015328A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ633900A0 (en) 2000-03-20 2000-04-15 Jurox Pty Ltd Anaesthetic composition
CN1322863C (zh) * 2004-10-29 2007-06-27 武汉远大制药集团股份有限公司 一种抑制血小板凝聚的注射液及其制备方法
CN100386079C (zh) * 2005-03-24 2008-05-07 武汉远大制药集团股份有限公司 一种抑制血小板凝聚的注射用粉针及其制备方法
CN100367961C (zh) * 2005-09-30 2008-02-13 天津南开允公医药科技有限公司 盐酸替罗非班冻干粉针注射剂及其制备方法
CN102125519B (zh) * 2011-02-28 2012-07-11 正大青春宝药业有限公司 稳定的盐酸替罗非班注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931441A (en) * 1988-11-09 1990-06-05 Luitpold Pharmaceuticals, Inc. Stabilized aqueous leucovorin calcium compositions
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
IL123790A0 (en) 1998-10-30
CA2234364A1 (en) 1997-05-01
BG63623B1 (bg) 2002-07-31
UA45423C2 (uk) 2002-04-15
DE69619540D1 (de) 2002-04-04
CN1200676A (zh) 1998-12-02
EP0859634A1 (en) 1998-08-26
MX9803275A (es) 1998-09-30
IS1948B (is) 2004-10-13
NO324415B1 (no) 2007-10-08
EP0859634B1 (en) 2002-02-27
EA000628B1 (ru) 1999-12-29
IS4699A (is) 1998-03-24
CN1158107C (zh) 2004-07-21
HUP9902521A3 (en) 2000-01-28
NO981869D0 (no) 1998-04-24
CY2292B1 (en) 2003-07-04
IL123790A (en) 2001-11-25
ATE213648T1 (de) 2002-03-15
PL185744B1 (pl) 2003-07-31
PT859634E (pt) 2002-07-31
HUP9902521A2 (hu) 1999-12-28
CO4770960A1 (es) 1999-04-30
CA2234364C (en) 2000-02-08
NO981869L (no) 1998-04-24
WO1997015328A1 (en) 1997-05-01
KR100362799B1 (ko) 2003-07-16
NZ323134A (en) 1999-11-29
SA96170527B1 (ar) 2005-12-21
TW385248B (en) 2000-03-21
EE03518B1 (et) 2001-10-15
KR19990067020A (ko) 1999-08-16
SK282353B6 (sk) 2002-01-07
BR9610878A (pt) 1999-07-13
DZ2110A1 (fr) 2002-07-22
BG102405A (en) 1999-08-31
EA199800336A1 (ru) 1998-10-29
CZ127898A3 (cs) 1998-10-14
DE69619540T2 (de) 2002-08-22
EE9800134A (et) 1998-10-15
ES2171749T3 (es) 2002-09-16
AU712755B2 (en) 1999-11-18
JPH10512296A (ja) 1998-11-24
AU7718996A (en) 1997-05-15
SK51298A3 (en) 1998-12-02
CZ290381B6 (cs) 2002-07-17
JP3452367B2 (ja) 2003-09-29
SI0859634T1 (en) 2002-04-30
PL326419A1 (en) 1998-09-14
MY116837A (en) 2004-04-30
TR199800716T2 (xx) 1998-07-21
HK1017846A1 (en) 1999-12-03
HU228757B1 (en) 2013-05-28

Similar Documents

Publication Publication Date Title
GB1418822A (en) Imidazo-and pyrimido-2,1-b-quinazolin-2-ones and a process for the preparation thereof
BR9911300A (pt) Composto, composição farmacêutica, e, uso do composto
DK0859634T3 (da) Farmaceutiske præparater indeholdende blodpladeaggregeringsinhibitorer
ES8305366A1 (es) "procedimiento para la preparacion de derivados de penem".
GB1322482A (en) Glutamic acid derivatives their preparation and compositions containing the same
HUP9800631A2 (hu) 4-Amino-tetrahidrobenzizoxazol- és 4-amino-tetrahidrobenzizotiazol-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk gyógyszerkészítmények előállítására
ATE34661T1 (de) Verbindungen zur verminderung des lipidspiegels.
GB1443692A (en) 1,2-diphenylethanolamine derivatives and their salts and the preparation thereof
KR900701262A (ko) 췌장염 등에 대한 치료제
KR980002033A (ko) 트리아졸 유도체 또는 그 염
IE832939L (en) Pharmaceutical composition.
GB1451389A (en) Indolobenzazepines
GB1530848A (en) 2-(phenylalkylhydrazono)-propionic acid derivatives
GB1208231A (en) beta-PHENETHYLAMINE DERIVATIVES AND A PROCESS FOR THE MANUFACTURE THEREOF
GB1468079A (en) Ethanolamine derivatives
KR900014360A (ko) 피리딘카복실산 아미드 유도체 및 이를 함유하는 약학 조성물
ATE21908T1 (de) Derivate von 1,4-diaminocyclitol, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GB1272527A (en) Propanolamine derivatives
GB1446164A (en) Basic enol ethers their salts processes for their preparation and pharmaceutical preparations containing the same
GB1267282A (en) Pharmaceutical compositions containing coumermycin derivatives
ES8302670A1 (es) Procedimiento de preparacion de nuevos derivados 2-hidroxi- metil-quinoxalino-1,4-dioxidos
GB1264128A (xx)
GB1384441A (en) Benzomorphan derivatives
GB1414938A (en) 6-aza-1,2-dihydro-3h-1,4-benzodiazepines
TH8005B (th) องค์ประกอบสำหรับใช้ทางปาก (Oral Composition)